Smartwatch with heart rate monitor icon on colorful diagonal striped background

Driving Innovation and Change via Patient Engagement Dashboard

Comprehensive, Organization-Wide Patient Engagement Improves Product Development and Clinical Trial Design
 

Source
The PFMD Book of Good Practices, First Edition

Link
Driving Innovation and Change via PE Dashboard
 

Description of Case Study

Janssen developed a patient engagement dashboard and accompanying tools to systematically incorporate patient perspectives into internal decision-making and product development activities. Gathering insights from patients across multiple conditions enabled developers to embed these insights into product strategy, clinical development, protocol design, and other internal processes, ensuring that development decisions better reflected patients’ experiences, priorities, and unmet needs.
 

Quick Facts

Organization name: Janssen
Organization type: pharmaceutical company
Product category: other: digital tool
Region(s) of patient engagement activities: Asia: Korea, Taiwan; Australia: Australia;
Europe: UK; North America: US
Total product life cycle stage(s): discovery/preclinical; clinical/testing;
evaluation/authorization; post-approval surveillance/monitoring

 

Product Type(s)

digital health technology:

  • non-health system software
     

Product Medical Specialty Area(s)

  • not listed
     

Stakeholders

  • patients and caregivers, patient organizations
  • regulators
  • health technology assessors
  • payers (public/private)
  • providers (clinicians, hospital/health system administrators)
  • other: policymakers
     

Methods and Sources of Patient Input

  • patient advisory boards
  • interviews/focus groups/surveys
  • journey mapping
  • patient-developed solutions
     

Impact of Patient Engagement

  • Improved clinical trial design: Patient feedback led to changes in clinical trial procedures, including reordering study activities, reducing visit burden, and refining protocol design. Authors cited improved clinical trial recruitment and retention as well as a better overall patient trial experience.
  • Informed product development: Patient insights influenced target product profiles, product strategy, device design, dosing approaches, and customer value considerations.
  • Aligned to patient-centered outcomes: Direct patient input prompted teams to prioritize outcomes that mattered to patients, including fatigue, sleep, and symptom experience, and supported development of new patient-reported outcome measures and symptom diaries.
  • Integrated patient input into research and development (R&D) decision-making: Patient perspectives were systematically incorporated into internal planning tools and decision-making processes across R&D.
  • Supported developing disease-related educational materials: Multiple disease areas utilized patient input in the development of educational materials.
     

Lessons Learned

  • Patients can have an impact at multiple touchpoints: Patient perspectives can improve decisions across product strategy, clinical development, protocol design, and patient-facing resources.
  • Patients identify overlooked priorities: Direct engagement revealed important issues, such as fatigue and study burden, that were not fully recognized through traditional development processes.
  • Use fit-for-purpose engagement methods: Different development questions require different patient engagement approaches rather than a single methodology.
  • Developing a comprehensive approach helps make patient engagement more consistent: Integrating patient perspectives into routine planning tools and governance processes helps make patient-centered decision-making more consistent across the organization.